Is Eupraxia Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Eupraxia Pharmaceuticals Inc (EPRX.TO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Eupraxia Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Eupraxia Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Eupraxia Pharmaceuticals Inc?

Muslim investors may consider investing in Eupraxia Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Eupraxia Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Eupraxia Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Eupraxia Pharmaceuticals Inc updated?

The Shariah compliance status of Eupraxia Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Eupraxia Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Eupraxia Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Eupraxia Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

EPRX.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 27, 2026

Report Source: 2025 Annual Report

Eupraxia Pharmaceuticals Inc. Stock Analysis EPRX.TO

Canada Health Care Small Cap Report: 2025 Annual

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. The company is headquartered in Victoria, British Columbia and currently employs 49 full-time employees. The company went IPO on 2021-03-09. The firm is focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The Company’s EP-104GI is in a Phase Ib/IIa trial, the RESOLVE trial, for the treatment of eosinophilic esophagitis (EoE). EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. The firm also completed a Phase IIb clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. In addition, the Company is developing a pipeline of later and earlier-stage long-acting formulations. Its potential pipeline indications include candidates for other inflammatory joint indications and oncology.

Key Statistics of Eupraxia Pharmaceuticals Inc (EPRX.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD9.47CAD9.90

Today's Open

CAD9.90

Volume

52.95K

P/E Ratio (TTM)

52 Week Range

CAD5.01CAD12.86

Market Cap

619.95M

Avg. Volume

42.67K

Dividend Yield

Financial Metrics & Statements of Eupraxia Pharmaceuticals Inc (EPRX.TO)

FAQ's for Eupraxia Pharmaceuticals Inc (EPRX.TO)

According to Musaffa’s Shariah screening methodology, Eupraxia Pharmaceuticals Inc (EPRX.TO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.